List of Tables:
TABLE 1 GLOBAL CANCER BIOLOGICAL THERAPY MARKET, BY TYPE, 2014-2023 (USD Million)
TABLE 2 MONOCLONAL ANTIBODIES FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION, 2014-2023 (USD Million)
TABLE 3 INTERFERONS FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD Million)
TABLE 4 INTERLEUKINS FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD Million)
TABLE 5 CANCER GROWTH INHIBITORS FOR CANCER BIOLOGIC THERAPY MARKET, BY REGION 2014-2023 (USD Million)
TABLE 6 GENE THERAPY FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD Million)
TABLE 7 COLONY STIMULATING FACTOR FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD Million)
TABLE 8 GLOBAL CANCER BIOLOGICAL THERAPY MARKET, BY END USER, 2014-2023 (USD Million)
TABLE 9 HOSPITALS & CLINICS FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD Million)
TABLE 10 CANCER RESEARCH CENTERS FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD Million)
TABLE 11 LABORATORIES FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD Million)
TABLE 12 GLOBAL CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD Million)
TABLE 13 North America CANCER BIOLOGICAL THERAPY MARKET, BY COUNTRY 2014-2023 (USD Million)
TABLE 14 North America BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 15 North America BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 16 U.S. CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 17 U.S. CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 18 Canada CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 19 Canada CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 20 EUROPE CANCER BIOLOGICAL THERAPY MARKET, BY COUNTRY 2014-2023 (USD Million)
TABLE 21 EUROPE CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 22 EUROPE CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 23 Germany CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 24 Germany CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 25 France CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 26 France CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 27 UK CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 28 UK CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 29 Italy CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 30 Italy CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 31 SPAIN CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 32 SPAIN CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 33 ROE CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 34 ROE CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 35 ASIA PACIFIC CANCER BIOLOGICAL THERAPY MARKET, BY COUNTRY 2014-2023 (USD Million)
TABLE 36 ASIA PACIFIC CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 37 ASIA PACIFIC CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 38 JAPAN CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 39 JAPAN CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 40 China CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 41 China CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 42 India CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 43 India CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 44 REPUBLIC OF KOREA CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 45 REPUBLIC OF KOREA CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 46 ROA CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 47 ROA CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 48 MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD Million)
TABLE 49 MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 50 MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 51 MIDDLE EAST CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 52 MIDDLE EAST CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 53 AFRICA CANCER BIOLOGICAL THERAPY MARKET, BY TYPE 2014-2023 (USD Million)
TABLE 54 AFRICA CANCER BIOLOGICAL THERAPY MARKET, BY END USER 2014-2023 (USD Million)
TABLE 55 AMGEN INC.: KEY DEVELOPMENT
LIST OF FIGURE
List of Figures:
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET DYNAMICS FOR GLOBAL CANCER BIOLOGICAL THERAPY MARKET
FIGURE 3 ATTRITION RATE OF PHASE III CLINICAL TRIALS IN EUROPE, 2012 (%)
FIGURE 4 CANCER BIOLOGICAL THERAPY SUCCESS RATES IN VARIOUS PHASES OF CLINICAL TRIALS
FIGURE 5 GLOBAL CANCER BIOLOGICAL THERAPY MARKET SHARE, BY TYPE 2016
FIGURE 6 GLOBAL CANCER BIOLOGICAL THERAPY MARKET SHARE, BY END USER, 2016
FIGURE 7 GLOBAL CANCER BIOLOGICAL THERAPY MARKET SHARE, BY REGION, 2016
FIGURE 8 North America CANCER BIOLOGICAL THERAPY MARKET SHARE, BY COUNTRY, 2016
FIGURE 9 EUROPE CANCER BIOLOGICAL THERAPY MARKET SHARE, BY COUNTRY, 2016
FIGURE 10 ASIA PACIFIC CANCER BIOLOGICAL THERAPY MARKET SHARE, BY COUNTRY, 2016
FIGURE 11 MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET, BY REGION, 2016
FIGURE 12 QATAR: CANCER INCIDENCE AND MORTALITY RATES (%)
FIGURE 13 UAE: CANCER INCIDENCE AND MORTALITY RATES (%)
FIGURE 14 KUWAIT: CANCER INCIDENCE AND MORTALITY RATES (%)
FIGURE 15 BAHRAIN: CANCER INCIDENCE AND MORTALITY RATES (%)
FIGURE 16 OMAN: CANCER INCIDENCE AND MORTALITY RATES (%)
FIGURE 17 SAUDI ARABIA: CANCER INCIDENCE AND MORTALITY RATES (%)
FIGURE 18 GLOBAL CANCER BIOLOGICAL THERAPY MARKET: COMPANY SHARE ANALYSIS, 2015 (%)
FIGURE 19 AMGEN INC.: KEY FINANCIALS
FIGURE 20 AMGEN INC.: SEGMENTAL REVENUE
FIGURE 21 AMGEN INC.: GEOGRAPHICAL REVENUE
FIGURE 22 BRISTOL-MYERS SQUIBB.: KEY FINANCIALS
FIGURE 23 BRISTOL-MYERS SQUIBB.: SEGMENTAL REVENUE
FIGURE 24 BRISTOL-MYERS SQUIBB: GEOGRAPHICAL REVENUE
FIGURE 25 CELGENE CORPORATION.: KEY FINANCIALS
FIGURE 26 CELGENE CORPORATION.: SEGMENTAL REVENUE
FIGURE 27 CELGENE CORPORATION: GEOGRAPHICAL REVENUE
FIGURE 28 ELI LILLY AND COMPANY.: KEY FINANCIALS
FIGURE 29 ELI LILLY AND COMPANY.: SEGMENTAL REVENUE
FIGURE 30 ELI LILLY AND COMPANY: GEOGRAPHICAL REVENUE
FIGURE 31 F. HOFFMANN-LA ROCHE AG: FINANCIAL REVENUE
FIGURE 32 F. HOFFMANN-LA ROCHE AG: SEGMENTAL REVENUE
FIGURE 33 F. HOFFMANN-LA ROCHE AG: GEOGRPAHICAL REVENUE
FIGURE 34 MERCK & CO., INC: FINANCIAL REVENUE
FIGURE 35 MERCK & CO., INC: SEGMENTAL REVENUE
FIGURE 36 MERCK & CO., INC: GEOGRPAHICAL REVENUE
FIGURE 37 NOVARTIS: FINANCIAL REVENUE
FIGURE 38 NOVARTIS: SEGMENTAL REVENUE
FIGURE 39 NOVARTIS: GEOGRPAHICAL REVENUE
FIGURE 40 PFIZER INC: FINANCIAL REVENUE
FIGURE 41 PFIZER INC: SEGMENTAL REVENUE
FIGURE 42 PFIZER INC: GEOGRPAHICAL REVENUE
